Study Suggests Emergency Contraception Potential For Regular Use
This article was originally published in The Tan Sheet
Executive Summary
Authors of a literature review suggest that 0.75 mg doses of levonorgestrel, currently used as an emergency contraceptive, may be safe and effective as a primary means of birth control in some populations but note that "rigorous new" safety and efficacy data would be needed to support such use.
You may also be interested in...
Teva's Plan B One-Step OTC Application Puts FDA On The Spot
Teva Pharmaceutical Industries asks FDA to allow over-the-counter sales of Plan B One-Step, starting the likely final leg of the emergency contraceptive's journey toward OTC status.
FDA Will Wait To Act On Plan B Petition Despite Contempt Complaint
FDA does not plan to look at allowing wider access to nonprescription emergency contraceptive Plan B until Teva Pharmaceuticals files an application, despite a complaint accusing the agency of ignoring a court order to reconsider age restrictions on the product.
Unilever Announces Corporate Restructuring Amid Reports Of Activist Investor Influence
Around 1,500 senior and junior management roles will be cut under Unilever’s announced plan to reshape its corporate matrix, the firm reports on 25 January. The news comes a day after reports that activist investor Nelson Peltz of Trian Fund Management has taken a stake in the business.